Sittner & Nelson’s BioNTech BNTX Stock Holding History

Sittner & Nelson’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.3K	Hold	100	–	–	﹤0.01%	454
2026 Q1	$8.89K	Hold	100	–	–	﹤0.01%	441
2025 Q4	$10.7K	Hold	100	–	–	﹤0.01%	399
2025 Q3	$9.86K	Hold	100	–	–	﹤0.01%	376
2025 Q2	$10.6K	Hold	100	–	–	﹤0.01%	375
2025 Q1	$9.11K	Hold	100	–	–	﹤0.01%	374
2024 Q4	$11.4K	Hold	100	–	–	﹤0.01%	342
2024 Q3	$11.9K	Hold	100	–	–	0.01%	332
2024 Q2	$8.04K	Hold	100	–	–	﹤0.01%	363
2024 Q1	$9.22K	Hold	100	–	–	﹤0.01%	350
2023 Q4	$10.6K	Hold	100	–	–	0.01%	338
2023 Q3	$10.9K	Hold	100	–	–	0.01%	334
2023 Q2	$10.8K	Hold	100	–	–	0.01%	338
2023 Q1	$12.5K	Hold	100	–	–	0.01%	345
2022 Q4	$15K	Hold	100	–	–	0.01%	306
2022 Q3	$13K	Hold	100	–	–	0.01%	299
2022 Q2	$15K	Hold	100	–	–	0.01%	316
2022 Q1	$17K	Buy	+100	New	+$16.8K	0.01%	288

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Sittner & Nelson's BNTX Position: Q2 2026 in Review

Sittner & Nelson held its BioNTech (BNTX) position steady in Q2 2026 at 100 shares worth $9.3K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

Sittner & Nelson first reported a position in BNTX in Q1 2022 and has held it in 18 quarters since. The position peaked at $17K in Q1 2022. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Sittner & Nelson held 100 shares of BioNTech worth $9.3K as of Q2 2026.
Sittner & Nelson left its BioNTech share count unchanged in Q2 2026.
BioNTech made up ﹤0.01% of Sittner & Nelson's portfolio in Q2 2026, its #454 holding.
Sittner & Nelson first reported a position in BioNTech in Q1 2022 and has held it in 18 quarters since.
Sittner & Nelson's BioNTech position peaked at $17K in Q1 2022.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Sittner & Nelson's 13F filing for Q2 2026, filed 7 Aug 2026.